Tratamentos naturais para controle da ansiedade: revisão crítica de ensaios clínicos randomizados e quase randomizados

Contenido principal del artículo

Larissa Soares
Marina Antonino
José Miguel Vicente Gomila
Claudia Tavares-Silva
Andrea Fonseca-Golçalves
Lucianne Cople Maia

Resumen

Objetivo: Evaluar tratamientos naturales incorporados a la medicina complementaria, alternativa e integrativa para el control de los trastornos de ansiedad (TA) a través de una revisión crítica de ensayos clínicos aleatorizados y cuasialeatorizados. Materiales y métodos: Se utilizaron cinco bases de datos electrónicas según los criterios de elegibilidad. Luego de eliminar duplicados y leer títulos y resúmenes, los datos fueron tabulados en Excel® 2016 y VantagePoint™. Se realizó un análisis descriptivo de las variables tipo de tratamiento, grupo de edad, presentación del fármaco, producto natural, eficacia y efectos adversos, revista y su factor de impacto, número de citas en las bases de datos Scopus y Google Scholar. Resultados: Treinta estudios fueron incluidos. El estudio más citado tiene 337 citas en Google Scholar y 192 en Scopus. De los tratamientos, 28 (93,33%) fueron fitoterápicos, uno (3,33%) homeopático y uno (3,33%) remedios florales. Quince estudios se realizaron en adultos, 14 en adultos y ancianos y uno en adolescentes. Cápsula (n=18), pastilla (n=6) y solución (n=1) fueron las presentaciones de los medicamentos, con efecto positivo clínicamente probado (n=25; 83%). Se han informado náuseas, mareos, dolores de cabeza y somnolencia. Piper methysticum, Matricaria recutita, Ginkgo biloba, Passiflora incarnata, Withania somnifera y Centella asiatica fueron los productos naturales estudiados. Conclusión: Los tratamientos naturales incorporados a la medicina complementaria, alternativa e integrativa para el control de la de han sido publicados en los últimos 24 años, especialmente en países desarrollados y en revistas con variado factor de impacto. La fitoterapia es el tipo de tratamiento más utilizado para la disfunción eréctil y sus efectos positivos han sido clínicamente probados.

Descargas

Los datos de descargas todavía no están disponibles.

Detalles del artículo

Cómo citar
Soares, L., Antonino, M. ., Vicente Gomila, J. M. ., Tavares-Silva, C., Fonseca-Golçalves, A., & Cople Maia, L. (2024). Tratamentos naturais para controle da ansiedade: revisão crítica de ensaios clínicos randomizados e quase randomizados . Revista Brasileira Multidisciplinar, 27(3), 155-170. https://doi.org/10.25061/2527-2675/ReBraM/2024.v27i3.1906
Sección
Artigos de Revisão

Citas

Amsterdam, J. D., Li, Q. S., Xie, S. X., & Mao, J. J. (2020). Putative antidepressant effect of chamomile (Matricaria chamomilla L.) oral extract in subjects with comorbid generalized anxiety disorder and depression. The Journal of Alternative and Complementary Medicine, 26(9), 815-821.

Amsterdam, J. D., Li, Y., Soeller, I., Rockwell, K., Mao, J. J., & Shults, J. (2009). A randomized, double-blind, placebo-controlled trial of oral Matricaria recutita (chamomile) extract therapy for generalized anxiety disorder. J Clin Psychopharmacol, 29(4), 378-382. doi: 10.1097/JCP.0b013e3181ac935c

APA , A. P. A. (2013). Diagnostic and statistical manual of mental disorders: DSM-5. United States.

Baker, D. G., Myers, S. P., Howden, I., & Brooks, L. (2003). The effects of homeopathic Argentum nitricum on test anxiety. Complement Ther Med, 11(2), 65-71.

Bhattacharyya, D., Sur, T., Jana, U., & Debnath, P. (2008). Controlled programmed trial of Ocimum sanctum leaf on generalized anxiety disorders. Nepal Med Coll J, 10(3), 176-179.

Bourin, M., Bougerol, T., Guitton, B., & Broutin, E. (1997). A combination of plant extracts in the treatment of outpatients with adjustment disorder with anxious mood: controlled study versus placebo. Fundam Clin Pharmacol, 11(2), 127-132.

Bystritsky, A., Kerwin, L., & Feusner, J. D. (2008). A pilot study of Rhodiola rosea (Rhodax) for generalized anxiety disorder (GAD). J Altern Complement Med, 14(2), 175-180. doi: 10.1089/acm.2007.7117

Carmona, F., Coneglian, F. S., Batista, P. A., Aragon, D. C., Angelucci, M. A., Martinez, E. Z., & Pereira, A. M. S. (2019). Aloysia polystachya (Griseb.) Moldenke (Verbenaceae) powdered leaves are effective in treating anxiety symptoms: A phase-2, randomized, placebo-controlled clinical trial. Journal of ethnopharmacology, 242, 112060.

Colalto, C. (2018). What phytotherapy needs: Evidence-based guidelines for better clinical practice. Phytother Res, 32(3), 413-425. doi: 10.1002/ptr.5977

Combs, H., & Markman, J. (2014). Anxiety disorders in primary care. Medical Clinics, 98(5), 1007-1023.

Connolly, S. D., & Bernstein, G. A. (2007). Practice parameter for the assessment and treatment of children and adolescents with anxiety disorders. Journal of the American Academy of Child & Adolescent Psychiatry, 46(2), 267-283.

Connor, K. M., & Davidson, J. R. (2002). A placebo-controlled study of Kava kava in generalized anxiety disorder. Int Clin Psychopharmacol, 17(4), 185-188. doi: 10.1097/00004850-200207000-00005

Contatore, O. A., Tesser, C. D., & Barros, N. F. d. (2018). Chinese medicine/acupuncture: historical notes on the colonization of a body of knowledge. História, Ciências, Saúde-Manguinhos, 25(3), 841-858.

Donthu, N., Kumar, S., Mukherjee, D., Pandey, N., & Lim, W. M. (2021). How to conduct a bibliometric analysis: An overview and guidelines. Journal of Business Research, 133, 285-296.

Ernst, E. (2010). Bach flower remedies: a systematic review of randomised clinical trials. Swiss Med Wkly, 140, w13079. doi: 10.4414/smw.2010.13079

Fajemiroye, J. O., da Silva, D. M., de Oliveira, D. R., & Costa, E. A. (2016). Treatment of anxiety and depression: medicinal plants in retrospect. Fundam Clin Pharmacol, 30(3), 198-215. doi: 10.1111/fcp.12186

Fuladi, S., Emami, S. A., Mohammadpour, A. H., Karimani, A., Manteghi, A. A., & Sahebkar, A. (2020). Assessment of Withania somnifera root extract efficacy in patients with generalized anxiety disorder: A randomized double-blind placebo-controlled trial. Current clinical pharmacology.

Gastpar, M., & Klimm, H. (2003). Treatment of anxiety, tension and restlessness states with Kava special extract WS® 1490 in general practice: A randomized placebo-controlled double-blind multicenter trial. Phytomedicine, 10(8), 631-639.

Hanus, M., Lafon, J., & Mathieu, M. (2004). Double-blind, randomised, placebo-controlled study to evaluate the efficacy and safety of a fixed combination containing two plant extracts (Crataegus oxyacantha and Eschscholtzia californica) and magnesium in mild-to-moderate anxiety disorders. Current medical research and opinion, 20(1), 63-71.

Jana, U., Sur, T., Maity, L., Debnath, P., & Bhattacharyya, D. (2010). A clinical study on the management of generalized anxiety disorder with Centella asiatica. Nepal Med Coll J, 12(1), 8-11.

Kasper, S., Gastpar, M., Müller, W. E., Volz, H.-P., Möller, H.-J., Dienel, A., & Schläfke, S. (2010). Silexan, an orally administered Lavandula oil preparation, is effective in the treatment of ‘subsyndromal’anxiety disorder: a randomized, double-blind, placebo controlled trial. Int Clin Psychopharmacol, 25(5), 277-287.

Kasper, S., Möller, H.-J., Volz, H.-P., Schläfke, S., & Dienel, A. (2017). Silexan in generalized anxiety disorder: investigation of the therapeutic dosage range in a pooled data set. Int Clin Psychopharmacol, 32(4), 195-204.

Keefe, J. R., Mao, J. J., Soeller, I., Li, Q. S., & Amsterdam, J. D. (2016). Short-term open-label chamomile (Matricaria chamomilla L.) therapy of moderate to severe generalized anxiety disorder. Phytomedicine, 23(14), 1699-1705.

Kobak, K. A., vH Taylor, L., Warner, G., & Futterer, R. (2005). St. John's wort versus placebo in social phobia: results from a placebo-controlled pilot study. Journal of Clinical Psychopharmacology, 25(1), 51-58.

Kuchta, K., de Nicola, P., & Schmidt, M. (2018). Randomized, dose‐controlled double‐blind trial: Efficacy of an ethanolic kava (Piper methysticum rhizome) extract for the treatment of anxiety in elderly patients. Traditional & Kampo Medicine, 5(1), 3-10.

Kupfer, D. J. (2015). Anxiety and DSM-5. Dialogues in clinical neuroscience, 17(3), 245.

Lakhan, S. E., & Vieira, K. F. (2010). Nutritional and herbal supplements for anxiety and anxiety-related disorders: systematic review. Nutrition journal, 9, 42-42. doi: 10.1186/1475-2891-9-42

Leonti, M., & Verpoorte, R. (2017). Traditional Mediterranean and European herbal medicines. J Ethnopharmacol, 199, 161-167. doi: 10.1016/j.jep.2017.01.052

Li, F. S., & Weng, J. K. (2017). Demystifying traditional herbal medicine with modern approach. 3, 17109. doi: 10.1038/nplants.2017.109

Lopresti, A. L., Drummond, P. D., Inarejos-García, A. M., & Prodanov, M. (2018). Affron®, a standardised extract from saffron (Crocus sativus L.) for the treatment of youth anxiety and depressive symptoms: a randomised, double-blind, placebo-controlled study. Journal of affective disorders, 232, 349-357.

Mao, J. (2016). Long-term chamomile for generalized anxiety disorder: A randomized controlled trial. J. Altern. Complement. Med., Volume 22(Issue 6), A59

Mao, J. J., Xie, S. X., Keefe, J. R., Soeller, I., Li, Q. S., & Amsterdam, J. D. (2016). Long-term chamomile (Matricaria chamomilla L.) treatment for generalized anxiety disorder: A randomized clinical trial. Phytomedicine, 23(14), 1735-1742.

Mazidi, M., Shemshian, M., Mousavi, S. H., Norouzy, A., Kermani, T., Moghiman, T., . . . Ferns, G. A. (2016). A double-blind, randomized and placebo-controlled trial of Saffron (Crocus sativus L.) in the treatment of anxiety and depression. J Complement Integr Med, 13(2), 195-199. doi: 10.1515/jcim-2015-0043

Nematolahi, P., Mehrabani, M., Karami-Mohajeri, S., & Dabaghzadeh, F. (2018). Effects of Rosmarinus officinalis L. on memory performance, anxiety, depression, and sleep quality in university students: A randomized clinical trial. Complement Ther Clin Pract, 30, 24-28.

Organization, W. H. (2004). Promoting mental health: Concepts, emerging evidence, practice: Summary report: World Health Organization.

Park, D.-M., Kim, S.-H., Park, Y.-C., Kang, W.-C., Lee, S.-R., & Jung, I.-C. (2014). The comparative clinical study of efficacy of Gamisoyo-San (Jiaweixiaoyaosan) on generalized anxiety disorder according to differently manufactured preparations: multicenter, randomized, double blind, placebo controlled trial. Journal of ethnopharmacology, 158, 11-17.

Pilkington, K., Kirkwood, G., Rampes, H., Fisher, P., & Richardson, J. (2006). Homeopathy for anxiety and anxiety disorders: a systematic review of the research. Homeopathy, 95(3), 151-162. doi: 10.1016/j.homp.2006.05.005

Posadzki, P., Watson, L. K., & Ernst, E. (2013). Adverse effects of herbal medicines: an overview of systematic reviews. Clin Med (Lond), 13(1), 7-12. doi: 10.7861/clinmedicine.13-1-7

Primi, R. (2010). Psychological assessment in Brazil: foundations, current situation and future directions. Psicologia: Teoria e Pesquisa, 26, 25-35.

Ravindran, A. V., Balneaves, L. G., Faulkner, G., Ortiz, A., McIntosh, D., Morehouse, R. L., . . . Group, C. D. W. (2016). Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 5. Complementary and Alternative Medicine Treatments. Canadian journal of psychiatry. Revue canadienne de psychiatrie, 61(9), 576-587. doi: 10.1177/0706743716660290

Ross, S. M. (2013). Generalized anxiety disorder (GAD): efficacy of standardized Matricaria recutita (German chamomile) extract in the treatment of generalized anxiety disorder. Holistic Nursing Practice, 27(6), 366-368.

Sarris, J. (2018). Herbal medicines in the treatment of psychiatric disorders: 10-year updated review. Phytother Res, 32(7), 1147-1162. doi: 10.1002/ptr.6055

Sarris, J., Byrne, G. J., Bousman, C. A., Cribb, L., Savage, K. M., Holmes, O., . . . Nazareth, S. (2020). Kava for generalised anxiety disorder: A 16-week double-blind, randomised, placebo-controlled study. Australian & New Zealand Journal of Psychiatry, 54(3), 288-297.

Sarris, J., Kavanagh, D. J., Adams, J., Bone, K., & Byrne, G. (2009). Kava Anxiety Depression Spectrum Study (KADSS): A mixed methods RCT using an aqueous extract of Piper methysticum. Complement Ther Med, 17(3), 176-178.

Sarris, J., Kavanagh, D. J., Byrne, G., Bone, K., Adams, J., & Deed, G. (2009). The Kava Anxiety Depression Spectrum Study (KADSS): a randomized, placebo-controlled crossover trial using an aqueous extract of Piper methysticum. Psychopharmacology, 205(3), 399-407.

Sarris, J., Stough, C., Bousman, C. A., Wahid, Z. T., Murray, G., Teschke, R., . . . Schweitzer, I. (2013). Kava in the treatment of generalized anxiety disorder: a double-blind, randomized, placebo-controlled study. Journal of Clinical Psychopharmacology, 33(5), 643-648.

Şenel, E. (2019). Evolution of homeopathy: A scientometric analysis of global homeopathy literature between 1975 and 2017. Complement Ther Clin Pract, 34, 165-173. doi: 10.1016/j.ctcp.2018.11.018

Stub, T., Musial, F., Kristoffersen, A. A., Alræk, T., & Liu, J. (2016). Adverse effects of homeopathy, what do we know? A systematic review and meta-analysis of randomized controlled trials. Complement Ther Med, 26, 146-163. doi: 10.1016/j.ctim.2016.03.013

Vanzeler, M. L. A. (2020). Anxiety disorders and psychological evaluation: Instruments used in Brazil. Revista Científica Multidisciplinar Núcleo do Conhecimento, 13, 110-120.

Volz, H.-P., & Kieser, M. (1997). Kava-kava extract WS 1490 versus placebo in anxiety disorders-a randomized placebo-controlled 25-week outpatient trial. Pharmacopsychiatry, 30(01), 1-5.

Walach, H., Rilling, C., & Engelke, U. (2001). Efficacy of Bach-flower remedies in test anxiety: a double-blind, placebo-controlled, randomized trial with partial crossover. Journal of Anxiety Disorders, 15(4), 359-366.

Woelk, H., Arnoldt, K., Kieser, M., & Hoerr, R. (2007). Ginkgo biloba special extract EGb 761® in generalized anxiety disorder and adjustment disorder with anxious mood: a randomized, double-blind, placebo-controlled trial. Journal of psychiatric research, 41(6), 472-480.